Chandan Healthcare divested its 53.56% stake in Chandan Pharmacy to a group company for ₹16.77 Cr.

This strategic move sharpens focus on higher-margin diagnostics.

Proceeds will fund new diagnostic centres, aiming to boost consolidated profitability and transparency for investors.